Barinthus Biotherapeutics Q3 EPS $(0.37) Down From $0.22 YoY
Portfolio Pulse from Benzinga Newsdesk
Barinthus Biotherapeutics reported a Q3 EPS of $(0.37), a decrease from $0.22 YoY.
November 09, 2023 | 9:58 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barinthus Biotherapeutics' Q3 earnings per share (EPS) decreased to $(0.37) from $0.22 year over year (YoY).
Earnings per share (EPS) is a key indicator of a company's profitability. A decrease in EPS is generally seen as a negative sign by investors, which could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100